Are big changes on the horizon for Siemens Healthineers?

Michael Walter | | Radiology Business | Economics

Siemens is expected to list a minority of its healthcare division, Siemens Healthineers, in the first half of 2018. The division is looking to cut costs now ahead of the move.

The listing is expected to value Siemens Healthineers at approximately $49 billion, according to Reuters. The funds would help Siemens pay for “its own investments and acquisitions as the industry moves toward more personalized care.”

“Analysts have said they would be looking for clues on how Siemens plans to turn around the underperforming in vitro diagnostics business, which provides lab machinery to analyze blood, tissue or urine samples,” Reuters pointed out in its reporting.

Two sources familiar with the situation say the sale is planned for March.

Click the link below to read the full story.

Siemens' Healthineers in pre-IPO cost-cutting drive

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers
Congress ditches doc fix in stopgap end-of-year funding bill
Teleradiology provider inks post-acute care deal worth $1.5M annually
US Radiology Specialists affiliate expands into new market
Radiologist rails against insurer’s refusal to cover key interventional service
Blue Cross Blue Shield affiliate rejects MRI contrast coverage, labeling it ‘investigational’

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.